Published in Hospital and Nursing Home Week, August 10th, 2006
Central to this expansion is the introduction of mass-based purification systems. LC/MS purification has supplanted conventional, less-specific UV detectors as the method of choice for peptide purification. The utilization of this technology in the Sigma-Genosys manufacturing process has significantly increased throughput. Analytical capabilities also have been augmented by the introduction of MS/MS detection. This combination of mass based systems with expanded synthesis capacity creates a state-of-the-art manufacturing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.